Open AccessTreatment of patients with advanced gastrointestinal stromal tumor of small bowel: Implications of imatinib mesylate
Author(s) -
ChunNan Yeh
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i23.3760
Subject(s) - medicine , imatinib mesylate , gastroenterology , gist , pdgfra , stromal tumor , survival rate , oncology , stromal cell , imatinib , myeloid leukemia
To examine the impact of imatinib mesylate (Glivec) on patient survival and response and its safety, and the correlation of the response rate with the kit gene mutation status.